Latest

cholinesterase inhibitors

This shows a model of a head and a brain

·March 27, 2021·4 min read

Common Alzheimer’s Treatment Linked to Slower Cognitive Decline

Cholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.

Featured Neurology Neuroscience

·October 3, 2019·3 min read

Pesticides likely caused ‘Havana syndrome’ that affected Cuba-based diplomats

Initially believed to be an acoustic attack, researchers now believe they have pinpointed a possible cause of the bizarre neurological symptoms reported by diplomats in Cuba in 2016. Researchers say a possible source for 'Havana syndrome' is exposure to cholinesterase inhibitors via organophosphorus insecticides.

Featured Neurology

·November 10, 2017·3 min read

Smell Test Challenge Suggests Clinical Benefit for Some Before Development of Alzheimer’s

Columbia researchers have identified a way in which to determine if a patient with MCI may respond to cholinesterase inhibitors.

Image shows neurons and dendritic spines.

Featured Neurology Open Neuroscience Articles

·February 23, 2016·3 min read

Brain Injury Recovery Boosted by Longer and More Intense Rehabilitation

Longer and more intense rehabilitation following stroke or TBI may produce greater benefits for recovery, a new study reports.

The image shows a brain affected by severe alzheimer's disease.

Featured Neuroscience

·May 7, 2013·3 min read

Turning Alzheimer’s Fuzzy Signals Into High Definition

Researchers have discovered how cholinesterase inhibitors, a class of drug that prevents the breakdown of acetylcholine, could sharpen the brain's performance in patients with Alzheimer's disease.